Viewray, Inc. (VRAY)

Trade VRAY now with
9/16/2019 7:32:58 AM ViewRay: Penn State Health Enters Master Agreement For The Purchase Of Up To Four MRIdian Systems
8/8/2019 5:52:54 PM ViewRay Cuts 2019 Total Revenue Outlook Range To $80 Mln-$95 Mln
7/16/2019 4:06:37 PM ViewRay Appoints Gail Wilensky To Its Board Of Directors
3/14/2019 4:12:28 PM ViewRay Q4 Loss/share $0.17 Vs. Loss $0.38 Year Ago
2/21/2019 5:32:37 AM ViewRay Announces FDA 510(k) Clearance For MRIdian MRI-Guided Radiation Therapy System
1/4/2019 5:33:03 AM ViewRay Announces First Patient Enrolled In SMART Trial For Locally Advanced Pancreatic Cancer
10/2/2018 7:31:33 AM ViewRay Appoints James Alecxih As Chief Commercial Officer
8/14/2018 11:05:43 PM ViewRay Announces Pricing Of Underwritten Public Offering Of 16.22 Mln Shares At $9.25/shr
8/14/2018 4:28:50 PM ViewRay Announces Proposed Public Offering Of Common Stock
8/3/2018 7:34:43 AM ViewRay Q2 Loss Per Share $0.30 Vs Loss $0.15 Last Year
7/24/2018 4:32:58 PM ViewRay Appoints Scott Drake As President, CEO And Director
5/10/2018 4:24:28 PM ViewRay Q1 Loss/share $0.11 Vs. Loss $0.54 Year Ago
3/14/2018 8:33:00 AM ViewRay Announces Order For MRIdian MR Image-guided Linac At University Hospital Zurich In Zurich
3/12/2018 7:36:29 AM ViewRay Q4 Net Loss $24.6 Mln Or $0.38 Per Share